Huiyi Ye

机构：Chinese PLA General Hospital · ORCID：0000-0001-7848-3573

发表论文 109 篇 · 总被引 1454 次 · h-index 17

代表论文

• Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 131)
• Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients (2021 · Frontiers in Oncology · 被引 72)
• A study on the adsorption behaviors of three hydrophobic quinolones by ordered mesoporous CMK-3 (2022 · Chemosphere · 被引 29)
• Diagnostic and prognostic value of MRI-based Node-RADS for the assessment of regional lymph node metastasis in renal cell carcinoma (2024 · Diagnostic and Interventional Imaging · 被引 16)
• Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score (2023 · Abdominal Radiology · 被引 11)
• Mucinous tubular and spindle cell carcinomas of the kidney (MTSCC-Ks): CT and MR imaging characteristics (2022 · Japanese Journal of Radiology · 被引 7)